Therapeutics Segment Held Largest Share of Pulmonary Devices Market in 2019
According to our new market research study on "North America Pulmonary Devices Market to 2027 – Regional Analysis and Forecast by Type, Application and End User" the market is expected to reach US$ 16,637.44 million by 2027 from US$ 7,581.04 million in 2019; it is estimated to grow at a CAGR of 10.3% from 2020 to 2027. The report provides trends prevailing in the North America pulmonary devices market and the factors driving the market growth along with those hindering it.
In 2019, the therapeutic devices held the largest share in the market and are forecasted to retain its dominance till 2027. The multi-modal and multi-functional use of therapeutic devices for a wide range of pulmonary diseases is expected to account for the growth of the therapeutic devices segment over the coming years. On the other hand, consumables and accessories is expected to witness fastest growth rate owing to the increasing trend for stockpiling of facial disposable masks to avoid viral transmission.
The growth of the North America pulmonary devices market is mainly attributed to the technological advancements in pulmonary devices by top market players coupled with robust commercial performances exhibited by various players in the US in the country. Moreover, the US FDA approval for emergency use of respiratory devices in management of the COVID-19 pandemic has also led to a crucial growth of the market in 2020. However, the unfavorable reimbursement scenario associated with the pulmonary device is the major factor hindering the market growth in North America.
ResMed; Masimo; Invacare Corporation; Koninklijke Philips N.V.; and Getinge AB are among the leading companies operating in the North America pulmonary devices market.
The Report Segments North America Pulmonary devices Market as Follows:
North America Pulmonary devices Market – By Type
North America Pulmonary devices Market – By Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Sleep Apnea
- Asthma
- Infectious Diseases
- Others
North America Pulmonary devices Market – By End User
North America Pulmonary devices Market – By Country
- North America
- US
- Canada
- Mexico